A detailed history of National Bank Of Canada transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, National Bank Of Canada holds 132 shares of MEDP stock, worth $45,262. This represents 0.0% of its overall portfolio holdings.

Number of Shares
132
Previous 1,643 91.97%
Holding current value
$45,262
Previous $664,000 91.87%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

SELL
$372.0 - $424.34 $562,092 - $641,177
-1,511 Reduced 91.97%
132 $54,000
Q1 2024

May 13, 2024

BUY
$284.87 - $413.31 $459,495 - $666,669
1,613 Added 5376.67%
1,643 $664,000
Q2 2023

Jul 26, 2023

SELL
$187.26 - $240.17 $17,789 - $22,816
-95 Reduced 76.0%
30 $7,000
Q1 2023

Apr 12, 2023

SELL
$174.31 - $239.52 $43,577 - $59,880
-250 Reduced 66.67%
125 $23,000
Q4 2022

Jan 24, 2023

BUY
$153.06 - $226.57 $52,805 - $78,166
345 Added 1150.0%
375 $0
Q4 2021

Jan 24, 2022

BUY
$182.74 - $227.9 $5,482 - $6,837
30 New
30 $7,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.7B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.